Goldman Sachs’s Amrize Ltd AMRZ Stock Holding History

Goldman Sachs’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-53,800	Closed	-$2.61M	–	6939
2025 Q3	$2.61M	Sell	53,800 -193,800	-78%	-$9.88M	﹤0.01%	4249
2025 Q2	$12.3M	Buy	+247,600	New	+$12.5M	﹤0.01%	2577

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's AMRZ Position: Q2 2026 in Review

Goldman Sachs increased its Amrize Ltd (AMRZ) stake by 47% in Q2 2026, buying an estimated $40.2M and bringing the position to 2,340,155 shares worth $125M. The position accounts for 0.01% of the portfolio, ranked #1072.

Goldman Sachs first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $213M in Q3 2025. 465 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

Goldman Sachs held 2,340,155 shares of Amrize Ltd worth $125M as of Q2 2026.
Goldman Sachs bought 743,120 Amrize Ltd shares in Q2 2026, an estimated $40.2M.
Amrize Ltd made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1072 holding.
Goldman Sachs first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
Goldman Sachs's Amrize Ltd position peaked at $213M in Q3 2025.
465 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.